Banking giant selects Tesla stock as ‘top pick', updates TSLA price

Morgan Stanley has reiterated its bullish stance on Tesla, naming it a top U.S. auto pick and raising its price target to $410, citing the company's leadership in AI and physical scaling capabilities. This positive outlook comes despite recent challenges, including an 8.4% year-over-year decline in Tesla's China EV sales in July, increased competition, and concerns over CEO Elon Musk's public image. Concurrently, Tesla's board approved a substantial new 96 million share restricted stock grant for Musk, valued at approximately $30 billion, pending regulatory approval, signaling continued commitment to his leadership amidst these market dynamics.

Analysis

A significant divergence exists between Tesla's long-term strategic valuation and its near-term operational performance. Morgan Stanley has reiterated a strong bullish conviction, elevating its price target to $410 and positioning Tesla as a top U.S. auto pick based on its leadership in scalable physical AI, robotics, and energy infrastructure. This forward-looking thesis, however, is set against a backdrop of immediate challenges. Notably, sales of its China-made vehicles fell 8.4% year-over-year in July, with total unit deliveries dropping 5.2% from June, highlighting intensifying competition and market saturation. Compounding this, the stock is entering a historically weak seasonal period from August to October. In a move to secure long-term leadership amidst these pressures, the board has approved a new $30 billion restricted stock grant for CEO Elon Musk, which is pending regulatory approval under the Hart-Scott-Rodino Act and includes a five-year lock-up period, signaling a strong commitment but also introducing governance and regulatory variables.

Key Decisions for Investors

• Investors must weigh the long-term, AI-driven bull case articulated by Morgan Stanley against tangible short-term headwinds, specifically the 8.4% year-over-year sales decline in the crucial Chinese market.
• It is critical to monitor upcoming monthly delivery figures from China and the status of regulatory approval for the CEO's new compensation package, as these are key near-term catalysts.
• Consider the stock's historical seasonal weakness between August and October, which could present a strategic entry point for long-term bulls or a period requiring increased caution for existing holders.
• The new CEO compensation award, while designed to ensure leadership stability, introduces governance risk and potential for further shareholder scrutiny that should be factored into any investment thesis.